First Patient Enrolled in SELUTION SLR IDE BTK Study
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LEIPZIG, Germany, June 8, 2022 /PRNewswire-AsiaNet/ -- The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval."I am excited to ...
Authors: LATEST ASIANET NEWS RELEASES